News | News By Subject | News by Disease News By Date | Search News

Obesity News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Novo Nordisk A/S (NVO)’s Diabetes Drug Beats Out Eli Lilly (LLY)’s Trulicity in Phase III Trials     8/17/2017
SoCal Biotech Arena (ARNA) Officially Bails on Weight Loss Drug to Focus on New Products     1/5/2017
Zafgen (ZFGN) Pinks Slips 34% of Workforce, Scraps Lead Obesity Drug After Deaths     7/21/2016
Citius Pharma Discontinues Development of Weight Loss Drug Suprenza     7/5/2016
Takeda (TKPYY) Sells U.S. Rights to Contrave Back to Orexigen (OREX), Establishes New Business Units     3/15/2016
Zafgen (ZFGN) Surges as Obesity Drug Succeeds in Phase IIb Trial     2/18/2016
Zafgen (ZFGN) Falls as Hedge Fund Shorts Stock, Claims Obesity Drug Will Not Gain FDA Approval     1/25/2016
Rhythm Wins FDA Breakthrough Tag for Setmelanotide for the Treatment Of POMC Deficiency Obesity     1/7/2016
Zafgen (ZFGN) Plunges Some More After FDA Orders Full Clinical Hold on Beloranib     12/3/2015
Zafgen (ZFGN) Plagued By More Bad News as Second Patient Dies in Obesity Drug Trial     12/2/2015
Johnson & Johnson (JNJ) Unit, Hanmi Pharma Ink Diabetes and Obesity Pact Worth $915 Million     11/9/2015
Embattled Zafgen (ZFGN) Continues Obesity Clinical Trials Despite Patient Death and Pending Class Action Lawsuit     10/22/2015
GlaxoSmithKline (GSK), University of California, Los Angeles (UCLA) Researchers Will Work Together on New Collaborative R&D Model     10/20/2015
After Patient Death in Zafgen (ZFGN)'s Phase III Obesity Study, FDA Places Partial Hold on Trial     10/16/2015
Emisphere (EMIS), Novo Nordisk A/S (NVO) Ink $221 Million+ Deal Develop Oral Formulations of Four Molecules Targeting Metabolic Indications     10/15/2015

News from Around the Web
No More 'Bad Fat'? A Potential Weight-Loss Treatment Could Make Fat Burn Itself, Washington University in St. Louis Study Reveals     9/20/2017
Boston Rare Disease Biopharma Rhythm Seeks $115 Million IPO     9/6/2017
'Activity Inequality' Could Be One Of The Biggest Factors In Obesity, Stanford Study Reveals     7/17/2017
This Man Wants To Sell You A $300 ‘Fasting Diet’ To Prolong Your Life—And It Might Not Be As Crazy As It Sounds     6/14/2017
Obesity Linked To Chemical Substitutes Found In Food Containers? University of Iowa Study Reveals     6/14/2017
What’s Weighing Down The Billion-Dollar Obesity Drug Market?     5/9/2017
Obesity And 4 Other Conditions Lead Americans To The Grave, Cleveland Clinic Study     4/28/2017
Could A Worm Gene Be The Key To Conquering Obesity? Monash University Study     2/14/2017
Stephen Hawking Is Right But Also Wrong About Obesity     12/5/2016
Soda Taxes Are On Four City Ballots — Will They Make A Dent In Obesity?     11/8/2016
King's College London Scientists Find New Fat Clues In Feces     9/27/2016
Can Marijuana Really Reduce Pot Bellies And Obesity? Yale Study     9/20/2016
An Animal Biologist Has A Special Diet Plan For Mice     9/19/2016
Do You Overeat? Blame Childhood Stress, Texas Christian University Study     9/2/2016
Excess Weight Linked To 8 More Cancers, Washington University School of Medicine Reveals     8/31/2016

Press Releases
Global Genomics Group In Collaboration With Semmelweis University In Budapest, Hungary, Unravel The Heritability Of Adiposity, Paving The Way To New Drug Targets In Obesity And Non-Alcoholic Fatty Liver Disease     9/14/2017
Novo Nordisk A/S (NVO) Release: More People Treated With Once-Weekly Semaglutide Achieved Reductions In Both Glucose And Weight Vs. Comparator Treatments     9/12/2017
Boehringer Ingelheim And Gubra Collaborate To Develop Next Generation Obesity Treatments     9/7/2017
Apollo Endosurgery Announces CE Mark Approval For The ORBERA365 Managed Weight Loss System, Expanding The Indwell Period From 6 Months To 12 Months With The Gastric Balloon Category Leader     8/31/2017
Phase I Trials For Two Novel Treatments Of Obesity And/Or Diabetes Initiated By Zealand Pharma  (ZEAL.CO) Partner Boehringer Ingelheim     8/22/2017
Saniona's Partner, Productos Medix, S.A de S.V, Initiates Phase III Study For Tesofensine In Obesity     8/21/2017
Cincinnati Children's Hospital Medical Center Release: Scientists Propose Novel Therapy To Lessen Risk Of Obesity-Linked Disease     7/25/2017
Alcresta Snags FDA 510(K) Clearance for Use Of Relizorb in Kids     7/20/2017
European Patent Issued For Human And Pet Anti-Obesity Vaccine To Braasch Biotech     7/19/2017
Preveceutical Signs Research And Option Agreement With Uniquest Limited For Developing Dual-Gene Therapy Treatment For Diabetes And Obesity     7/17/2017
Harvard Pilgrim Institute Study Finds School-Aged Children Had Higher Amounts Of Body Fat If Mothers Consumed More Sugary Beverages While Pregnant     7/11/2017
SoCal's Neothetics (NEOT) Craters As Fat-Reduction Drug Flunks Phase II Study     6/26/2017
Vaccines, Not Diet, Are Causing Epidemic Of Obesity And Type 2 Diabetes According To New Paper From Classen Immunotherapies Inc.     6/26/2017
Aspire Bariatrics Announces Aspireassist Receives Australian TGA Approval And First Commercial Cases Performed In Australia     6/22/2017
American Diabetes Association Release: Severe Obesity In High-Risk Youth Correlates Directly To Increased Incidence Of Type 2 Diabetes     6/12/2017